nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—Piloerection—Irinotecan—colon cancer	0.101	0.101	CcSEcCtD
Midodrine—Heartburn—Fluorouracil—colon cancer	0.0244	0.0244	CcSEcCtD
Midodrine—Vasodilation procedure—Irinotecan—colon cancer	0.02	0.02	CcSEcCtD
Midodrine—Vasodilation—Irinotecan—colon cancer	0.02	0.02	CcSEcCtD
Midodrine—Drug interaction—Vincristine—colon cancer	0.0194	0.0194	CcSEcCtD
Midodrine—Hyperaesthesia—Capecitabine—colon cancer	0.015	0.015	CcSEcCtD
Midodrine—Urinary retention—Vincristine—colon cancer	0.0124	0.0124	CcSEcCtD
Midodrine—Irritability—Fluorouracil—colon cancer	0.0117	0.0117	CcSEcCtD
Midodrine—Dry skin—Fluorouracil—colon cancer	0.0112	0.0112	CcSEcCtD
Midodrine—Dysuria—Vincristine—colon cancer	0.0106	0.0106	CcSEcCtD
Midodrine—Sleep disorder—Capecitabine—colon cancer	0.00986	0.00986	CcSEcCtD
Midodrine—Stomatitis—Vincristine—colon cancer	0.00984	0.00984	CcSEcCtD
Midodrine—Hepatic function abnormal—Capecitabine—colon cancer	0.00977	0.00977	CcSEcCtD
Midodrine—Stomatitis—Irinotecan—colon cancer	0.00958	0.00958	CcSEcCtD
Midodrine—Hepatic enzyme increased—Methotrexate—colon cancer	0.00925	0.00925	CcSEcCtD
Midodrine—Stomatitis—Fluorouracil—colon cancer	0.00917	0.00917	CcSEcCtD
Midodrine—Bradycardia—Irinotecan—colon cancer	0.00898	0.00898	CcSEcCtD
Midodrine—Urinary tract disorder—Vincristine—colon cancer	0.00895	0.00895	CcSEcCtD
Midodrine—Urethral disorder—Vincristine—colon cancer	0.00888	0.00888	CcSEcCtD
Midodrine—Cardiac disorder—Vincristine—colon cancer	0.00841	0.00841	CcSEcCtD
Midodrine—Angiopathy—Vincristine—colon cancer	0.00822	0.00822	CcSEcCtD
Midodrine—Cardiac disorder—Irinotecan—colon cancer	0.00819	0.00819	CcSEcCtD
Midodrine—Flushing—Irinotecan—colon cancer	0.00819	0.00819	CcSEcCtD
Midodrine—Irritability—Capecitabine—colon cancer	0.00815	0.00815	CcSEcCtD
Midodrine—Urinary retention—Capecitabine—colon cancer	0.00811	0.00811	CcSEcCtD
Midodrine—Angiopathy—Irinotecan—colon cancer	0.008	0.008	CcSEcCtD
Midodrine—Mental disorder—Vincristine—colon cancer	0.00794	0.00794	CcSEcCtD
Midodrine—Chills—Irinotecan—colon cancer	0.00791	0.00791	CcSEcCtD
Midodrine—Dry skin—Capecitabine—colon cancer	0.00782	0.00782	CcSEcCtD
Midodrine—Back pain—Vincristine—colon cancer	0.00763	0.00763	CcSEcCtD
Midodrine—Flatulence—Irinotecan—colon cancer	0.00757	0.00757	CcSEcCtD
Midodrine—Back pain—Irinotecan—colon cancer	0.00743	0.00743	CcSEcCtD
Midodrine—Muscle spasms—Irinotecan—colon cancer	0.00738	0.00738	CcSEcCtD
Midodrine—Agitation—Vincristine—colon cancer	0.00725	0.00725	CcSEcCtD
Midodrine—Abdominal discomfort—Capecitabine—colon cancer	0.00707	0.00707	CcSEcCtD
Midodrine—Dysuria—Capecitabine—colon cancer	0.0069	0.0069	CcSEcCtD
Midodrine—Hypertension—Vincristine—colon cancer	0.00681	0.00681	CcSEcCtD
Midodrine—Hypertension—Irinotecan—colon cancer	0.00663	0.00663	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00652	0.00652	CcSEcCtD
Midodrine—Stomatitis—Capecitabine—colon cancer	0.00641	0.00641	CcSEcCtD
Midodrine—Confusional state—Irinotecan—colon cancer	0.00632	0.00632	CcSEcCtD
Midodrine—Nervous system disorder—Vincristine—colon cancer	0.00631	0.00631	CcSEcCtD
Midodrine—Hepatobiliary disease—Capecitabine—colon cancer	0.00622	0.00622	CcSEcCtD
Midodrine—Nervous system disorder—Irinotecan—colon cancer	0.00615	0.00615	CcSEcCtD
Midodrine—Irritability—Methotrexate—colon cancer	0.00606	0.00606	CcSEcCtD
Midodrine—Confusional state—Fluorouracil—colon cancer	0.00605	0.00605	CcSEcCtD
Midodrine—Bradycardia—Capecitabine—colon cancer	0.00601	0.00601	CcSEcCtD
Midodrine—Nervous system disorder—Fluorouracil—colon cancer	0.00589	0.00589	CcSEcCtD
Midodrine—Tachycardia—Fluorouracil—colon cancer	0.00586	0.00586	CcSEcCtD
Midodrine—Urinary tract disorder—Capecitabine—colon cancer	0.00583	0.00583	CcSEcCtD
Midodrine—Insomnia—Vincristine—colon cancer	0.00582	0.00582	CcSEcCtD
Midodrine—Urethral disorder—Capecitabine—colon cancer	0.00579	0.00579	CcSEcCtD
Midodrine—Paraesthesia—Vincristine—colon cancer	0.00578	0.00578	CcSEcCtD
Midodrine—Insomnia—Irinotecan—colon cancer	0.00567	0.00567	CcSEcCtD
Midodrine—Paraesthesia—Irinotecan—colon cancer	0.00563	0.00563	CcSEcCtD
Midodrine—Dyspnoea—Irinotecan—colon cancer	0.00559	0.00559	CcSEcCtD
Midodrine—Erythema multiforme—Capecitabine—colon cancer	0.00558	0.00558	CcSEcCtD
Midodrine—Somnolence—Irinotecan—colon cancer	0.00557	0.00557	CcSEcCtD
Midodrine—Gastrointestinal disorder—Vincristine—colon cancer	0.00556	0.00556	CcSEcCtD
Midodrine—Dyspepsia—Irinotecan—colon cancer	0.00552	0.00552	CcSEcCtD
Midodrine—Pain—Vincristine—colon cancer	0.0055	0.0055	CcSEcCtD
Midodrine—Cardiac disorder—Capecitabine—colon cancer	0.00548	0.00548	CcSEcCtD
Midodrine—Flushing—Capecitabine—colon cancer	0.00548	0.00548	CcSEcCtD
Midodrine—Insomnia—Fluorouracil—colon cancer	0.00543	0.00543	CcSEcCtD
Midodrine—Gastrointestinal disorder—Irinotecan—colon cancer	0.00541	0.00541	CcSEcCtD
Midodrine—Paraesthesia—Fluorouracil—colon cancer	0.00539	0.00539	CcSEcCtD
Midodrine—Pain—Irinotecan—colon cancer	0.00536	0.00536	CcSEcCtD
Midodrine—Angiopathy—Capecitabine—colon cancer	0.00536	0.00536	CcSEcCtD
Midodrine—Dyspnoea—Fluorouracil—colon cancer	0.00535	0.00535	CcSEcCtD
Midodrine—Somnolence—Fluorouracil—colon cancer	0.00534	0.00534	CcSEcCtD
Midodrine—Chills—Capecitabine—colon cancer	0.0053	0.0053	CcSEcCtD
Midodrine—Dyspepsia—Fluorouracil—colon cancer	0.00528	0.00528	CcSEcCtD
Midodrine—Abdominal discomfort—Methotrexate—colon cancer	0.00526	0.00526	CcSEcCtD
Midodrine—Gastrointestinal pain—Vincristine—colon cancer	0.00526	0.00526	CcSEcCtD
Midodrine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00518	0.00518	CcSEcCtD
Midodrine—Mental disorder—Capecitabine—colon cancer	0.00517	0.00517	CcSEcCtD
Midodrine—Feeling abnormal—Irinotecan—colon cancer	0.00516	0.00516	CcSEcCtD
Midodrine—Dysuria—Methotrexate—colon cancer	0.00513	0.00513	CcSEcCtD
Midodrine—Pain—Fluorouracil—colon cancer	0.00513	0.00513	CcSEcCtD
Midodrine—Gastrointestinal pain—Irinotecan—colon cancer	0.00512	0.00512	CcSEcCtD
Midodrine—Abdominal pain—Vincristine—colon cancer	0.00509	0.00509	CcSEcCtD
Midodrine—Flatulence—Capecitabine—colon cancer	0.00506	0.00506	CcSEcCtD
Midodrine—Back pain—Capecitabine—colon cancer	0.00497	0.00497	CcSEcCtD
Midodrine—Abdominal pain—Irinotecan—colon cancer	0.00495	0.00495	CcSEcCtD
Midodrine—Feeling abnormal—Fluorouracil—colon cancer	0.00495	0.00495	CcSEcCtD
Midodrine—Muscle spasms—Capecitabine—colon cancer	0.00494	0.00494	CcSEcCtD
Midodrine—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.00485	0.00485	CcSEcCtD
Midodrine—Stomatitis—Methotrexate—colon cancer	0.00477	0.00477	CcSEcCtD
Midodrine—Hepatobiliary disease—Methotrexate—colon cancer	0.00463	0.00463	CcSEcCtD
Midodrine—Asthenia—Vincristine—colon cancer	0.00462	0.00462	CcSEcCtD
Midodrine—Asthenia—Irinotecan—colon cancer	0.0045	0.0045	CcSEcCtD
Midodrine—Hypertension—Capecitabine—colon cancer	0.00444	0.00444	CcSEcCtD
Midodrine—Anxiety—Capecitabine—colon cancer	0.00436	0.00436	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00435	0.00435	CcSEcCtD
Midodrine—Urinary tract disorder—Methotrexate—colon cancer	0.00434	0.00434	CcSEcCtD
Midodrine—Urethral disorder—Methotrexate—colon cancer	0.00431	0.00431	CcSEcCtD
Midodrine—Dry mouth—Capecitabine—colon cancer	0.00428	0.00428	CcSEcCtD
Midodrine—Dizziness—Vincristine—colon cancer	0.00426	0.00426	CcSEcCtD
Midodrine—Pruritus—Fluorouracil—colon cancer	0.00425	0.00425	CcSEcCtD
Midodrine—Confusional state—Capecitabine—colon cancer	0.00423	0.00423	CcSEcCtD
Midodrine—Erythema multiforme—Methotrexate—colon cancer	0.00416	0.00416	CcSEcCtD
Midodrine—Dizziness—Irinotecan—colon cancer	0.00414	0.00414	CcSEcCtD
Midodrine—Nervous system disorder—Capecitabine—colon cancer	0.00411	0.00411	CcSEcCtD
Midodrine—Tachycardia—Capecitabine—colon cancer	0.00409	0.00409	CcSEcCtD
Midodrine—Cardiac disorder—Methotrexate—colon cancer	0.00408	0.00408	CcSEcCtD
Midodrine—Skin disorder—Capecitabine—colon cancer	0.00407	0.00407	CcSEcCtD
Midodrine—Rash—Vincristine—colon cancer	0.00406	0.00406	CcSEcCtD
Midodrine—Dermatitis—Vincristine—colon cancer	0.00405	0.00405	CcSEcCtD
Midodrine—Headache—Vincristine—colon cancer	0.00403	0.00403	CcSEcCtD
Midodrine—Angiopathy—Methotrexate—colon cancer	0.00399	0.00399	CcSEcCtD
Midodrine—Dizziness—Fluorouracil—colon cancer	0.00397	0.00397	CcSEcCtD
Midodrine—Rash—Irinotecan—colon cancer	0.00395	0.00395	CcSEcCtD
Midodrine—Dermatitis—Irinotecan—colon cancer	0.00395	0.00395	CcSEcCtD
Midodrine—Chills—Methotrexate—colon cancer	0.00394	0.00394	CcSEcCtD
Midodrine—Headache—Irinotecan—colon cancer	0.00393	0.00393	CcSEcCtD
Midodrine—Mental disorder—Methotrexate—colon cancer	0.00385	0.00385	CcSEcCtD
Midodrine—Nausea—Vincristine—colon cancer	0.00382	0.00382	CcSEcCtD
Midodrine—Insomnia—Capecitabine—colon cancer	0.00379	0.00379	CcSEcCtD
Midodrine—Rash—Fluorouracil—colon cancer	0.00378	0.00378	CcSEcCtD
Midodrine—Dermatitis—Fluorouracil—colon cancer	0.00378	0.00378	CcSEcCtD
Midodrine—Paraesthesia—Capecitabine—colon cancer	0.00377	0.00377	CcSEcCtD
Midodrine—Headache—Fluorouracil—colon cancer	0.00376	0.00376	CcSEcCtD
Midodrine—Dyspnoea—Capecitabine—colon cancer	0.00374	0.00374	CcSEcCtD
Midodrine—Nausea—Irinotecan—colon cancer	0.00372	0.00372	CcSEcCtD
Midodrine—Back pain—Methotrexate—colon cancer	0.0037	0.0037	CcSEcCtD
Midodrine—Dyspepsia—Capecitabine—colon cancer	0.00369	0.00369	CcSEcCtD
Midodrine—Gastrointestinal disorder—Capecitabine—colon cancer	0.00362	0.00362	CcSEcCtD
Midodrine—Pain—Capecitabine—colon cancer	0.00359	0.00359	CcSEcCtD
Midodrine—Nausea—Fluorouracil—colon cancer	0.00357	0.00357	CcSEcCtD
Midodrine—Feeling abnormal—Capecitabine—colon cancer	0.00346	0.00346	CcSEcCtD
Midodrine—Gastrointestinal pain—Capecitabine—colon cancer	0.00343	0.00343	CcSEcCtD
Midodrine—Abdominal pain—Capecitabine—colon cancer	0.00332	0.00332	CcSEcCtD
Midodrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00323	0.00323	CcSEcCtD
Midodrine—Confusional state—Methotrexate—colon cancer	0.00315	0.00315	CcSEcCtD
Midodrine—Nervous system disorder—Methotrexate—colon cancer	0.00306	0.00306	CcSEcCtD
Midodrine—Skin disorder—Methotrexate—colon cancer	0.00303	0.00303	CcSEcCtD
Midodrine—Asthenia—Capecitabine—colon cancer	0.00301	0.00301	CcSEcCtD
Midodrine—Pruritus—Capecitabine—colon cancer	0.00297	0.00297	CcSEcCtD
Midodrine—Insomnia—Methotrexate—colon cancer	0.00282	0.00282	CcSEcCtD
Midodrine—Paraesthesia—Methotrexate—colon cancer	0.0028	0.0028	CcSEcCtD
Midodrine—Dyspnoea—Methotrexate—colon cancer	0.00278	0.00278	CcSEcCtD
Midodrine—Somnolence—Methotrexate—colon cancer	0.00278	0.00278	CcSEcCtD
Midodrine—Dizziness—Capecitabine—colon cancer	0.00277	0.00277	CcSEcCtD
Midodrine—Dyspepsia—Methotrexate—colon cancer	0.00275	0.00275	CcSEcCtD
Midodrine—Gastrointestinal disorder—Methotrexate—colon cancer	0.0027	0.0027	CcSEcCtD
Midodrine—Pain—Methotrexate—colon cancer	0.00267	0.00267	CcSEcCtD
Midodrine—Rash—Capecitabine—colon cancer	0.00264	0.00264	CcSEcCtD
Midodrine—Dermatitis—Capecitabine—colon cancer	0.00264	0.00264	CcSEcCtD
Midodrine—Headache—Capecitabine—colon cancer	0.00263	0.00263	CcSEcCtD
Midodrine—Feeling abnormal—Methotrexate—colon cancer	0.00257	0.00257	CcSEcCtD
Midodrine—Gastrointestinal pain—Methotrexate—colon cancer	0.00255	0.00255	CcSEcCtD
Midodrine—Nausea—Capecitabine—colon cancer	0.00249	0.00249	CcSEcCtD
Midodrine—Abdominal pain—Methotrexate—colon cancer	0.00247	0.00247	CcSEcCtD
Midodrine—Asthenia—Methotrexate—colon cancer	0.00224	0.00224	CcSEcCtD
Midodrine—Pruritus—Methotrexate—colon cancer	0.00221	0.00221	CcSEcCtD
Midodrine—Dizziness—Methotrexate—colon cancer	0.00206	0.00206	CcSEcCtD
Midodrine—Rash—Methotrexate—colon cancer	0.00197	0.00197	CcSEcCtD
Midodrine—Dermatitis—Methotrexate—colon cancer	0.00197	0.00197	CcSEcCtD
Midodrine—Headache—Methotrexate—colon cancer	0.00196	0.00196	CcSEcCtD
Midodrine—Nausea—Methotrexate—colon cancer	0.00185	0.00185	CcSEcCtD
